IHH Healthcare wants Fortis Healthcare to pursue large hospital acquisitions to narrow the competitive distance with Apollo Hospitals and Manipal Health Enterprises. The Malaysian parent company, backed by Japan’s Mitsui and sovereign fund Khazanah, acquired Fortis in 2018 and now seeks to increase its stake while directing strategic expansion.

The directive reflects IHH’s assessment that organic growth alone won’t deliver the market positioning required in India’s consolidating healthcare sector. Apollo operates over 70 hospitals across 13 countries. Manipal runs 28 hospitals in India with international operations. Fortis manages 27 hospitals domestically.

What IHH hasn’t disclosed is whether Fortis’ independent directors have evaluated the capital allocation implications of acquisition-led growth versus other strategic options. Hospital M&A in India typically requires significant integration costs, regulatory approvals across multiple states, and often involves distressed assets with operational challenges.

The parent company’s push for both increased ownership and M&A activity creates a governance tension. Higher stake acquisition suggests IHH wants greater control over strategic decisions. Simultaneously directing large hospital purchases indicates the parent views Fortis’ current board-approved growth strategy as insufficient.

Fortis’ board approved a ₹1,500 crore expansion plan in 2023 focused on bed capacity increases at existing facilities and select greenfield projects. The Malaysian parent’s M&A directive represents a strategic pivot that independent directors must evaluate against shareholder returns, debt capacity, and integration risks.

Healthcare sector consolidation in India has accelerated as private equity and international players acquire mid-tier hospital chains. Quality Care India, Max Healthcare, and Medanta have all expanded through acquisitions in recent years. The strategy works when target hospitals operate in complementary geographies or provide specialized services that enhance the buyer’s portfolio.

IHH’s dual agenda of stake increase and M&A direction suggests the parent believes Fortis needs both additional capital and strategic repositioning. Whether Fortis’ independent directors share this assessment remains undisclosed in public filings.

My Boardroom Takeaway:

Nomination committees evaluating healthcare sector independent directors should probe their M&A evaluation experience. Hospital acquisitions involve regulatory complexity across multiple state jurisdictions and integration challenges that differ significantly from other sector consolidation plays. Directors may wish to establish clear criteria for evaluating parent company strategic directives against minority shareholder interests, particularly when the parent seeks simultaneous ownership increases and major capital deployment.